Acne Medication
The Global Acne Medication Market was valued at $8,017 million in 2017, and is projected to reach $10,929 million by 2025 at a CAGR of 3.9% from 2018 to 2025. Acne is a long-term skin disease that appears because of clogged hair follicles, dead skin cells, and oil excreted from skin.
The Global Acne Medication Market was valued at $8,017 million in 2017, and is projected to reach $10,929 million by 2025 at a CAGR of 3.9% from 2018 to 2025. Acne is a long-term skin disease that appears because of clogged hair follicles, dead skin cells, and oil excreted from skin.
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Acne</strong> <strong>Medication</strong><br />
Market<br />
Opportunity Analysis and Industry Forecast, 2016-2023<br />
Global Opportunity Analysis and<br />
Industry Forecast,<br />
2018-2025
<strong>Acne</strong> <strong>Medication</strong> Market<br />
<strong>Acne</strong> medications have gained a substantial market share in the recent years, due<br />
to high prevalence of acne vulgaris and high preferences for skin care products.<br />
Improved features of acne drugs and development of safer acne therapeutics have<br />
led to widening of applications of these medications for the treatment of acne,<br />
which have further supplemented the market growth. Furthermore, increase in<br />
strategic developments by key players is anticipated to fuel the market growth in<br />
the near future.<br />
- Pallavi Jaiswal
<strong>Acne</strong> <strong>Medication</strong> Market
<strong>Acne</strong> <strong>Medication</strong> Market<br />
<strong>Acne</strong> medications have gained a substantial market share in the recent years, due<br />
to high prevalence of acne vulgaris and high preferences for skin care products.<br />
Improved features of acne drugs and development of safer acne therapeutics have<br />
led to widening of applications of these medications for the treatment of acne,<br />
which have further supplemented the market growth. Furthermore, increase in<br />
strategic developments by key players is anticipated to fuel the market growth in<br />
the near future.<br />
- Pallavi Jaiswal
<strong>Acne</strong> <strong>Medication</strong> Market Overview<br />
The Global <strong>Acne</strong> <strong>Medication</strong> Market was valued at $8,017 million in 2017, and<br />
is projected to reach $10,929 million by 2025 at a CAGR of 3.9% from 2018 to<br />
2025. <strong>Acne</strong> is a long-term skin disease that appears because of clogged hair<br />
follicles, dead skin cells, and oil excreted from skin. It is characterized by<br />
presence of considerable number of pimples, whiteheads, blackheads, oily<br />
skin, and probable scarring. It generally affects skin with comparatively high<br />
number of sweat glands at upper part of chest, back, and face. <strong>Acne</strong><br />
medications are drugs that are indicated for the treatment of acne. These<br />
include several prescription and over-the-counter medicines such as retinoids,<br />
isotretinoin, antibiotics, salicylic acid, benzoyl peroxide, oral contraceptives<br />
and many more.
<strong>Acne</strong> <strong>Medication</strong> Market Overview<br />
<strong>Acne</strong> medications are drugs that are indicated for the treatment of acne. These<br />
include several prescription and over-the-counter medicines such as retinoids,<br />
isotretinoin, antibiotics, salicylic acid, benzoyl peroxide, oral contraceptives, and<br />
others.<br />
Request sample PDF at: https://www.alliedmarketresearch.com/requestsample/4356<br />
The factors that drive the growth of the acne medication market include increase in<br />
prevalence of acne vulgaris across the world, unhealthy urban lifestyle, surge in<br />
pollution, and rise in focus on skin care products. However, side effects associated<br />
with acne medications and reforms, and presence of alternative treatment options<br />
such as laser therapies, impede the market growth. Conversely, the development of<br />
newer products with lesser side effects and presence of untapped market in the<br />
emerging economies are expected to provide lucrative growth opportunities for the<br />
market.<br />
.
<strong>Acne</strong> <strong>Medication</strong> Market Overview<br />
The retinoids segment accounted for the largest share in 2017, owing to high<br />
usage in treatment of acne and lesser side effects as compared to other<br />
therapeutics. However, the salicylic acid segment is expected to grow at the high<br />
CAGR from 2018 to 2025<br />
Market Dynamics<br />
Increase in prevalence of acne vulgaris condition, especially in teenagers and<br />
adults drive the market growth. Other factors that boost the market growth<br />
include rise in adoption of skin care products, and unhealthy urban lifestyle that<br />
leads to acne development. However, factors such as side effects associated with<br />
medicines and presence of alternative acne treatment options such as laser<br />
therapies, hamper the market growth. Conversely, the development of effective<br />
therapeutics with lesser side effects and high potential in untapped markets in<br />
the emerging economies are expected to provide lucrative growth opportunities<br />
for the market.
<strong>Acne</strong> <strong>Medication</strong> Market Segmentation<br />
Market Segmentation<br />
The global acne medication market is segmented into therapeutic class,<br />
formulation, type, acne type, distribution channel, and region. Based on<br />
therapeutic class, the market is divided into retinoids, antibiotics, salicylic acid,<br />
benzoyl peroxide, and others. Retinoids segment is further divided into topical<br />
retinoid & combination retinoid and oral retinoid (isotretinoin). On the other hand,<br />
antibiotics segment is further sub-segmented into topical antibiotics & combination<br />
antibiotics, and oral antibiotics. Retinoids segment accounted for the largest<br />
market share in 2017, and is expected to continue this trend throughout the<br />
forecast period owing to high adoption of retinoids products and less side effects<br />
associated with retinoids. On the other hand, salicylic acid segment is anticipated to<br />
grow at a significant CAGR of 4.2% during the forecast period.<br />
The inflammatory acne segment is the largest acne type segment in the global acne<br />
medication market in 2017 and is expected to maintain its lead in the forecast<br />
period. On the other hand, non-inflammatory acne segment is anticipated to record<br />
the highest CAGR from 2018-2025.
<strong>Acne</strong> <strong>Medication</strong> Market Segmentation<br />
By type, the prescription medicine segment dominated the global acne<br />
treatment market in terms of revenue in 2017 and the trend is projected<br />
to continue throughout the forecast period.<br />
The utilization rate of topical medications for acne treatment is high owing<br />
to high availability of these products with high success rate and lesser side<br />
effects. However, the oral medication segment is expected to grow at a<br />
CAGR of 3.6% during the forecast period.<br />
Based on the formulation, the market is bifurcated into topical medications<br />
and oral medications where topical formulations hold maximum market<br />
share in 2017 and is anticipated to grow at a significant CAGR of 3.9%. On<br />
the basis of type, the market is segmented into prescription medicines and<br />
over-the-counter (OTC) medicines. Prescription medicines segment<br />
accounted for the largest market share in 2017 due to large number of<br />
patients seeking medical help for the treatment of acne and high<br />
preferences for safe medicines. Whereas, over-the-counter (OTC)<br />
medicines segment is expected to register the moderate growth rate<br />
during the forecast period.
Key Findings of <strong>Acne</strong> <strong>Medication</strong> Market<br />
Key Findings of the <strong>Acne</strong> <strong>Medication</strong> Market:<br />
The antibiotics segment accounted for nearly one-fourth share of the<br />
global acne medication market in 2017.<br />
The over-the-counter medicine segment is expected to grow at a CAGR of<br />
2.9% from 2018 to 2025.<br />
The non-inflammatory acne segment accounted for around two-fifths<br />
share of the global market in 2017.<br />
Europe accounted for around one-fourth share of the global market in<br />
2017.<br />
LAMEA is expected to provide lucrative market growth opportunities and<br />
grows with the CAGR of 4.5% from 2018 to 2025.
<strong>Acne</strong> <strong>Medication</strong> Market<br />
North America was the leading revenue contributor to the global acne<br />
medication market in 2017, and is expected to dominate the market during the<br />
forecast period. This is attributed to the early approval of acne medication<br />
products and high adoption of prescription medicines in this region. However,<br />
Asia-Pacific is expected to grow at the highest CAGR of 5.6% during the study<br />
period, due to increase in affordability, surge in healthcare expenditure, and<br />
rise in awareness toward safe acne medications products.<br />
Do purchase Inquiry at: https://www.alliedmarketresearch.com/purchaseenquiry/4356
Key Players of <strong>Acne</strong> <strong>Medication</strong> Market<br />
The key players of this market include Allergan Plc., Nestle S.A. (Galderma<br />
S.A.), Johnson & Johnson, Mayne Pharma Group Limited, Mylan N.V., Pfizer<br />
Inc., GlaxoSmithKline Plc (Stiefel Laboratories, Inc.), Sun Pharmaceutical<br />
Industries Limited, Teva Pharmaceutical Industries Ltd., and Valeant<br />
Pharmaceuticals International, Inc.<br />
Other players (these players are not profiled in the report and the same can<br />
be included on request) in the value chain include Daiichi Sankyo Company,<br />
Ltd., Ranbaxy Laboratories Limited, Medicis Pharmaceutical Corporation,<br />
Foamix Pharmaceuticals, Prestium Pharma, Inc. and BioPharmX, Inc.
Key Benefits of <strong>Acne</strong> <strong>Medication</strong> Market<br />
The study provides an in-depth analysis of the global acne medication<br />
market with current trends and future estimations from 2017 to 2025 to<br />
elucidate the imminent investment pockets.<br />
Comprehensive analysis of factors that drive and restrict the market<br />
growth is provided.<br />
Identification of factors instrumental in changing the market scenario, rise<br />
in opportunities, and identification of key companies that can influence<br />
this market on a global & regional scale are provided.<br />
Key players are profiled and their strategies are analyzed thoroughly to<br />
understand the competitive outlook of the market.
<strong>Acne</strong> <strong>Medication</strong> Market by Geography<br />
North America<br />
Europe<br />
Asia-Pacific<br />
LAMEA
<strong>Acne</strong> <strong>Medication</strong> Market<br />
Thank You!<br />
For More Details<br />
Visit us at<br />
https://www.alliedmarketresearch.com/acnemedication-market<br />
Follow Us On
Change language